Extended-release formulation for reducing the frequency of urination and method of use thereof
AssigneeWellesley Pharmaceuticals, LLC
InventorsDavid A. Dill, Ilya A. Volfson
Life of this patent
Estimating the term…
Abstract
A method for reducing the frequency of urination is disclosed. The method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising one or more analgesic agents and one or more α-blockers. In one embodiment, the one or more analgesic agents are formulated for extended-release.
Claims21
A pharmaceutical composition for reducing frequency of urination, comprising:
- acetaminophen and ibuprofen;
- one or more α-blockers, and
- a pharmaceutically acceptable carrier,
- wherein said acetaminophen and ibuprofen are formulated for extended release and wherein said one or more α-blockers are formulated for immediate release.
A pharmaceutical composition for reducing frequency of urination, comprising:
- acetaminophen and ibuprofen;
- one or more 5α-reductase inhibitors, and
- a pharmaceutically acceptable carrier
- wherein said acetaminophen and ibuprofen are formulated for extended release and wherein said one or more 5α-reductase inhibitors are formulated for immediate release.
A pharmaceutical composition for reducing frequency of urination, comprising:
- (1) acetaminophen and ibuprofen;
- (2) an α-blocker, a 5α-reductase inhibitor or both;
- and
- a pharmaceutically acceptable carrier.
A pharmaceutical composition consisting of three different types of active agents and one or more pharmaceutically acceptable carriers,
- wherein said three different types of active agents consist of acetaminophen, ibuprofen and an α-blocker.
A pharmaceutical composition consisting of three different types of active agents and one or more pharmaceutically acceptable carriers,
- wherein said three different types of active agents consist of acetaminophen, ibuprofen and a 5α-reductase inhibitor.
Dependencies are inferred from the claim text.